Education
About Us
Working with TipRanks
Follow Us
QuiaPEG Pharmaceuticals Holding AB (DE:99B0)
:99B0
Total Valuation
QuiaPEG Pharmaceuticals Holding AB has a market cap or net worth of €2.04M. The enterprise value is ―.
Market Cap€2.04M
Enterprise Value―
Share Statistics
QuiaPEG Pharmaceuticals Holding AB has 2,124,285,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,124,285,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
QuiaPEG Pharmaceuticals Holding AB’s return on equity (ROE) is -1.77 and return on invested capital (ROIC) is -175.28%.
Return on Equity (ROE)-1.77
Return on Assets (ROA)-1.27
Return on Invested Capital (ROIC)-175.28%
Return on Capital Employed (ROCE)-1.75
Revenue Per Employee0.00
Profits Per Employee-5.73M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of QuiaPEG Pharmaceuticals Holding AB is 0.00. QuiaPEG Pharmaceuticals Holding AB’s PEG ratio is 0.00.
PE Ratio0.00
PS Ratio42.43
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.00
Income Statement
In the last 12 months, QuiaPEG Pharmaceuticals Holding AB had revenue of 0.00 and earned -28.93M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit460.00K
Operating Income-28.66M
Pretax Income-28.93M
Net Income-28.93M
EBITDA-9.71M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -6.86M and capital expenditures 0.00, giving a free cash flow of -6.86M billion.
Operating Cash Flow-6.86M
Free Cash Flow-6.86M
Free Cash Flow per Share>-0.01
Dividends & Yields
QuiaPEG Pharmaceuticals Holding AB pays an annual dividend of €0.508, resulting in a dividend yield of ―
Dividend Per Share€0.508
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta12.57
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)132.59K
Important Dates
QuiaPEG Pharmaceuticals Holding AB upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateMar 3, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend DateMar 30, 2017
Financial Position
QuiaPEG Pharmaceuticals Holding AB as a current ratio of 0.16, with Debt / Equity ratio of 0.00%
Current Ratio0.16
Quick Ratio0.16
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio-108.17
Taxes
In the past 12 months, QuiaPEG Pharmaceuticals Holding AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
QuiaPEG Pharmaceuticals Holding AB EV to EBITDA ratio is <0.01, with an EV/FCF ratio of <0.01.
EV to Sales0.00
EV to EBITDA<0.01
EV to Free Cash Flow<0.01
EV to Operating Cash Flow<0.01
Balance Sheet
QuiaPEG Pharmaceuticals Holding AB has €2.58M in cash and marketable securities with kr2.34M in debt, giving a net cash position of €748.00K billion.
Cash & Marketable Securities€2.58M
Total Debtkr2.34M
Net Cash€748.00K
Net Cash Per Share<€0.01
Tangible Book Value Per Share€0.00
Margins
Gross margin is 73.94%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin73.94%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for QuiaPEG Pharmaceuticals Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―